Sweetgreen's stock dropped after weaker-than-expected second-quarter results and an accompanying analyst downgrade. The miss raises questions about traffic trends, unit economics, and near-term profitability, suggesting multiple compression in SG's valuation until clearer guidance arrives. The next earnings update and any guidance revisions will likely set the near-term trajectory for SG.
Sweetgreen slashed its full-year same-store-sales guidance after attributing weakness to a U.S. cyclosporiasis outbreak affecting fresh produce. The downgrade signals near-term demand headwinds and potential margin pressure from higher sourcing costs and promotions. A containment of the outbreak could help traffic, but investors should expect continued volatility until visibility improves.
Sweetgreen cut its full-year outlook, citing weaker demand for fresh-prepared foods amid a multistate cyclospora outbreak. It now guides 2026 SSS at -7% to -8% and adjusted EBITDA of -$27M to -$23M, far worse than prior guidance. The miss and revised forecast imply near-term margin pressure and elevated downside risk for SG stock.
Regulators tied the cyclosporiasis outbreak to iceberg lettuce from Taco Bell, easing concerns about Sweetgreen’s produce. SG states iceberg lettuce isn’t used in its menus, supporting a constructive sentiment shift despite a broader market pullback in produce stocks. The event highlights supply-chain resilience for SG, with risks centered on supplier recalls that could affect the broader sector.
Sweetgreen's same-store sales dropped 9.5% amid declining foot traffic. The company faces significant investor skepticism and an 80% price decline this year. Sweetgreen sold Spyce for $186.4 million, aiming to reduce costs and improve scalability. Only one-third of stores are profitable, indicating substantial room for improvement. Future expansion to 1,000 locations by 2030 remains a strategic goal.
Sweetgreen missed Q3 earnings estimates with a loss of 31 cents per share. Sales of $172.4M fell short of expectations of $179.62M. FY2025 sales guidance cut from $700-$715M to $682-$688M. Analysts adjusted price targets: Piper Sandler ($9), Wells Fargo ($10), RBC ($7). Sweetgreen shares dropped 10.8% to $5.57 after the earnings report.